Morlet N - Search Results

1

Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration.

Arnold JJ, Campain A, Barthelmes D, Simpson JM, Guymer RH, Hunyor AP, McAllister IL, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness Study Group. Arnold JJ, et al. Among authors: morlet n. Ophthalmology. 2015 Jun;122(6):1212-9. doi: 10.1016/j.ophtha.2015.02.009. Epub 2015 Apr 4. Ophthalmology. 2015. PMID: 25846847

2

High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.

Morlet N, Young S, Naidoo D, Fong T, Coroneo MT. Morlet N, et al. Br J Ophthalmol. 1995 Aug;79(8):753-5. doi: 10.1136/bjo.79.8.753. Br J Ophthalmol. 1995. PMID: 7547787 Free PMC article.

3

Effect of topical interferon-alpha 2b on corneal haze after excimer laser photorefractive keratectomy in rabbits.

Morlet N, Gillies MC, Crouch R, Maloof A. Morlet N, et al. Refract Corneal Surg. 1993 Nov-Dec;9(6):443-51. Refract Corneal Surg. 1993. PMID: 8117643

4

Prevention of intraocular pressure rise following intravitreal injection.

Morlet N, Young SH. Morlet N, et al. Br J Ophthalmol. 1993 Sep;77(9):572-3. doi: 10.1136/bjo.77.9.572. Br J Ophthalmol. 1993. PMID: 8218055 Free PMC article.

5

High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration.

Morlet N, Young S, Naidoo D, Graham G, Coroneo MT. Morlet N, et al. Br J Ophthalmol. 1996 Mar;80(3):214-6. doi: 10.1136/bjo.80.3.214. Br J Ophthalmol. 1996. PMID: 8703858 Free PMC article.

6

Topical interferon alpha 2b for corneal haze after excimer laser photorefractive keratectomy. The Melbourne Excimer Laser Group.

Gillies MC, Garrett SK, Shina SM, Morlet N, Taylor HR. Gillies MC, et al. Among authors: morlet n. J Cataract Refract Surg. 1996 Sep;22(7):891-900. doi: 10.1016/s0886-3350(96)80188-x. J Cataract Refract Surg. 1996. PMID: 9041079 Clinical Trial.

7

Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.

Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, Tuft S. Duguid IG, et al. Among authors: morlet n. Ophthalmology. 1997 Oct;104(10):1587-92. doi: 10.1016/s0161-6420(97)30092-x. Ophthalmology. 1997. PMID: 9331195

8

High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis.

Young S, Morlet N, Besen G, Wiley CA, Jones P, Gold J, Li Y, Freeman WR, Coroneo MT. Young S, et al. Among authors: morlet n. Ophthalmology. 1998 Aug;105(8):1404-10. doi: 10.1016/s0161-6420(98)98020-4. Ophthalmology. 1998. PMID: 9709750

9

Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)'s fifth report.

Ng JQ, Morlet N, Pearman JW, Constable IJ, McAllister IL, Kennedy CJ, Isaacs T, Semmens JB; Team EPSWA. Ng JQ, et al. Among authors: morlet n. Ophthalmology. 2005 Jul;112(7):1199-206. doi: 10.1016/j.ophtha.2005.01.050. Ophthalmology. 2005. PMID: 15921759

10

Quality of life after postoperative endophthalmitis.

Clark A, Ng JQ, Morlet N, Tropiano E, Mahendran P, Spilsbury K, Preen D, Semmens JB. Clark A, et al. Among authors: morlet n. Clin Exp Ophthalmol. 2008 Aug;36(6):526-31. doi: 10.1111/j.1442-9071.2008.01827.x. Clin Exp Ophthalmol. 2008. PMID: 18954314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters